Literature DB >> 27375880

Crystal structure of 3-(4-hy-droxy-phen-yl)-2-[(E)-2-phenyl-ethen-yl]quinazolin-4(3H)-one.

Inese Mierina1, Dmitrijs Stepanovs2, Jolita Kuginyte3, Artur Janichev2, Mara Jure1.   

Abstract

The title compound, C22H16N2O2 {systematic name: 3-(4-hy-droxy-phen-yl)-2-[(E)-2-phenyl-ethen-yl]quinazolin-4(3H)-one}, consists of a substituted 2-[(E)-2-aryl-ethen-yl]-3-aryl-quinazolin-4(3H)-one skeleton. The substituents at the ethyl-ene fragment are located in trans positions. The phenyl ring is inclined to the quinazolone ring by 26.44 (19)°, while the 4-hy-droxy-phenyl ring is inclined to the quinazolone ring by 81.25 (8)°. The phenyl ring and the 4-hy-droxy-phenyl ring are inclined to one another by 78.28 (2)°. In the crystal, mol-ecules are connected via O-H⋯O hydrogen bonds, forming a helix along the a-axis direction. The helices are linked by C-H⋯π inter-actions, forming slabs parallel to (001).

Entities:  

Keywords:  2,3-disubstituted quinazolin-4(3H)-one; crystal structure; hydrogen bonding; styrylquinazolinone conjugation system

Year:  2016        PMID: 27375880      PMCID: PMC4910336          DOI: 10.1107/S2056989016004473

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

Compounds containing the 2-[(E)-2-aryl­ethen­yl]-3-aryl­quinazolin-4(3H)-one core are well known for their broad biological activities. These compounds demonstrate anti­biotic effect in vivo against methicillin-resistant Staphylococcus aureus (Bouley et al., 2015 ▸; Chang et al., 2014 ▸) and anti­leishmanial activity (Birhan et al., 2014 ▸). 2-Styryl functional­ized quinazolinones are applicable as anti­cancer agents against human cell lines (Kamal et al., 2013 ▸; 2012 ▸; 2010 ▸) and anti­convulsants (Das et al., 2014 ▸). Analogues of the title compound are Hsp90 inhibitors with in vitro anti-tumor activity (Park et al., 2007 ▸), as well as suppressants of the ubiquitin ligase activity of a human polypeptide (Erez & Nakache, 2011 ▸), GluN2D-containing NMDA receptors (Hansen & Traynelis, 2011 ▸) and c-KIT expression (Wang et al., 2013 ▸). Compounds with such a structure are good modulators of both γ-secretase (Fischer et al., 2011 ▸) and Rho C activity (Sun et al., 2003 ▸), as well as AMPA receptor antagonists (Chenard et al., 2001 ▸; 1999 ▸; Welch & DeVries, 1998 ▸). Piriqualone (the 2-hetaryl­vinyl analogue of the above mentioned compounds) has been used as a sedative–hypnotic drug (Kumar et al., 2015 ▸).

Structural commentary

The title compound 1, Fig. 1 ▸, consists of a substituted 2-[(E)-2-aryl­ethen­yl]-3-aryl­quinazolin-4(3H)-one skeleton. The substituents at the ethyl­ene fragment are located in trans-positions. Unlike the structure reported by Nosova et al. (2012 ▸), where the conjugation system of styrylquinazolinone is practically planar, in compound 1 the 2-phenyl­eth-(E)-enyl substituent is twisted with respect to the plane of the quinazolone ring. The phenyl (C21–C26) and the 4-hy­droxy­phenyl (C12–C17) rings are inclined to one another by 78.2 (2)°, and to the quinazolone ring (N1/N2/C2/C4–C10) by 26.44 (19) and 81.25 (8)°, respectively. A similar styryl­quinazolinone conjugation system geometry has been found in structures reported previously (Trashakhova et al., 2011 ▸; Ovchinnikova et al., 2014 ▸).
Figure 1

The mol­ecular structure of compound 1, showing the atom labelling. Displacement ellipsoids are drawn at the 50% probability level.

Supra­molecular features

In the crystal of 1, mol­ecules are connected via O—H⋯O hydrogen bonds forming a 21 helix, with graph set C(3), propagating along the a-axis direction (Table 1 ▸ and Fig. 2 ▸). This is similar to the crystal packing reported for the structure of diltiazem acetyl­salicilate hydrate (Stepanovs et al., 2016 ▸). In 1, the helices are linked via C—H⋯π inter­actions, forming slabs lying parallel to the ab plane (Table 1 ▸ and Fig. 3 ▸).
Table 1

Hydrogen-bond geometry (Å, °)

Cg3 and Cg4 are the centroids of the C12–C17 and C21–C26 rings, respectively.

D—H⋯A D—HH⋯A DA D—H⋯A
O18—H18⋯O11i 0.821.842.654 (5)172
C4—H4⋯Cg4ii 0.942.963.829 (5)157
C16—H16⋯Cg3i 0.942.953.646 (5)133

Symmetry codes: (i) ; (ii) .

Figure 2

A fragment of the crystal structure of compound 1, showing the helix-like hydrogen-bonded chain propagating along the a-axis direction.

Figure 3

A view along the a axis of the crystal packing of compound 1. The hydrogen bonds are shown as dashed lines and the C—H⋯π inter­actions (see Table 1 ▸) are represented as thin black lines.

Database survey

A search of the Cambridge Structural Database (Version 5.37; Groom & Allen, 2014 ▸) for substructure S1 (Fig. 4 ▸) gave 137 hits, while a search for substructure S2 (2-aryl­vinyl 3-aryl quinazolin-4(3H)-one skeleton, Fig. 4 ▸) gave only three hits: Nosova et al. (2012 ▸); Trashakhova et al. (2011 ▸); Ovchinnikova et al. (2014 ▸). However, none of the characterized single crystals contains a hydrogen-bond donor/acceptor in the aryl substituent at position 3 of the quinazolinone unit and information on inter­molecular inter­actions of such structures is still missing. The only example containing a carb­oxy­lic functionality at the 3-aryl substituent of quinazolin-4(3H)-one was analysed as a complex with Staphylococcus aureus at the PBP2a binding site (Bouley et al., 2015 ▸).
Figure 4

Substructures used for the Database survey.

Synthesis and crystallization

The title compound 1 was synthesized applying two pathways starting from 2-methyl (2) or 2-styryl (3) benzoxazin-4-one (methods A and B, respectively, Fig. 5 ▸).
Figure 5

Synthesis of the title compound, 1.

2-Methyl benzoxazin-4-one (2) (0.263 g, 1.6 mmol) and 4-amino­phenol (4) (0.175 g, 1.6 mmol) in glacial acetic acid (2 ml) were refluxed for 7 h, then poured into crushed ice (50 ml) and filtered. Compound 5 was obtained as a greyish solid. Its spectroscopic data corresponded to those in the literature (Marinho & Proença, 2015 ▸). The crude product 5, without further purification, was subjected to condensation with benzaldehyde analogously to a known method (Krastina et al., 2014 ▸): 3-(4-hy­droxy­phen­yl)-2-methyl­quinazolin-4(3H)-one (5) (0.276 g, 1.1 mmol), benzaldehyde (0.27 g, 2.53 mol) and acetanhydride (0.5 ml) in acetic acid (4 ml) were refluxed for 8 h, poured into crushed ice (50 ml), filtered and air-dried. The mixture containing compounds 1 and 6 (0.25 g) was refluxed for 7 h in NaOH/methanol (5%, 5 ml), poured into crushed ice (50 ml), acidified with conc. hydro­chloric acid and filtered. The target compound 1 was obtained as a white solid with 53% (0.197 g) yield over two steps. The title compound 1 was obtained as a by-product during the synthesis of 2-cinnamamido-N-(4-hy­droxy­phen­yl)benz­amide: benzoxazin-4-one 3 (1.00 g, 4 mmol) and 4-amino­phenol (4) (0.44 g, 4 mmol) were refluxed in toluene (5 ml) for 3 h, then the mixture was filtered. The title compound was isolated by crystallization from ethanol. Single crystals suitable for X-ray analysis were obtained by slow evaporation from ethanol at room temperature (m.p. > 523 K). Spectroscopic data: IR (KBr), ν, cm−1: 3300 (OH), 1655 (CON), 1150, 1515, 1470, 1450, 1340, 1225, 970, 775, 965. 1H NMR (300 MHz, DMSO-d 6), δ (p.p.m.): 9.91 (1H, s, OH), 8.12 (1H, d, J = 7.8 Hz, H-5), 7.91–7.83 (2H, m, H-b, H-6/7), 7.76 (1H, d, J = 7.8 Hz, H-8), 7.52 (1H, t, J = 7.8 Hz, H-6/7), 7.41–7.33 (5H, m, Ph), 7.23 (2H, d, J = 8.6 Hz, H-1′), 6.94 (2H, d, J = 8.6 Hz, H-2′), 6.42 (1H, d, J = 15.4 Hz, H-a). 13C NMR (75 MHz, DMSO-d 6), δ (p.p.m.): 161.5, 157.8, 152.0, 147.4, 138.6, 134.9, 134.7, 129.9, 129.8, 129.1, 127.9, 127.4, 127.1, 126.52, 126.47, 120.6, 120.2, 116.1. HRMS. Calculated [M+H]+, m/z: 341.1285. C22H16N2O2. Found, m/z: 341.1282.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. The C-bound H atoms were positioned geometrically and refined as riding on their parent atoms: C—H = 0.93 − 0.98 Å with U iso(H) = 1.5U eq(C) for methyl H atoms and 1.2U eq(C) for other H atoms. The H atom of the hydroxyl group was included in the position identified from a difference Fourier map and was then refined as riding: O—H = 0.82 Å with U iso(H) = 1.5U eq(O).
Table 2

Experimental details

Crystal data
Chemical formulaC22H16N2O2
M r 340.37
Crystal system, space groupOrthorhombic, P21 n b
Temperature (K)173
a, b, c (Å)5.3469 (2), 16.5139 (6), 19.8885 (10)
V3)1756.12 (13)
Z 4
Radiation typeMo Kα
μ (mm−1)0.08
Crystal size (mm)0.22 × 0.18 × 0.09
 
Data collection
DiffractometerNonius KappaCCD
No. of measured, independent and observed [I > 2σ(I)] reflections3862, 3862, 2236
(sin θ/λ)max−1)0.649
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.068, 0.139, 1.03
No. of reflections3862
No. of parameters236
No. of restraints1
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å−3)0.17, −0.19

Computer programs: KappaCCD Server Software (Nonius, 1997 ▸), DENZO and SCALEPACK (Otwinowski & Minor, 1997 ▸), SIR2011 (Burla et al., 2012 ▸), ORTEP-3 for Windows (Farrugia, 2012 ▸), Mercury (Macrae et al., 2008 ▸), SHELXL2015 (Sheldrick, 2015 ▸), PLATON (Spek, 2009 ▸) and publCIF (Westrip, 2010 ▸).

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989016004473/su5288sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989016004473/su5288Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989016004473/su5288Isup3.cml CCDC reference: 1468806 Additional supporting information: crystallographic information; 3D view; checkCIF report
C22H16N2O2Dx = 1.287 Mg m3
Mr = 340.37Mo Kα radiation, λ = 0.71073 Å
Orthorhombic, P21nbCell parameters from 6856 reflections
a = 5.3469 (2) Åθ = 1.0–27.5°
b = 16.5139 (6) ŵ = 0.08 mm1
c = 19.8885 (10) ÅT = 173 K
V = 1756.12 (13) Å3Plate, colorless
Z = 40.22 × 0.18 × 0.09 mm
F(000) = 712
Nonius KappaCCD diffractometer2236 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeθmax = 27.5°, θmin = 3.2°
φ and ω scanh = −6→6
3862 measured reflectionsk = −21→21
3862 independent reflectionsl = −25→25
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.068H-atom parameters constrained
wR(F2) = 0.139w = 1/[σ2(Fo2) + (0.0478P)2 + 0.3939P] where P = (Fo2 + 2Fc2)/3
S = 1.03(Δ/σ)max < 0.001
3862 reflectionsΔρmax = 0.17 e Å3
236 parametersΔρmin = −0.19 e Å3
1 restraint
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
xyzUiso*/Ueq
N10.6956 (7)0.7742 (2)0.45545 (18)0.0333 (9)
C20.8449 (8)0.7044 (3)0.4584 (2)0.0317 (10)
N30.8479 (7)0.6500 (2)0.41192 (18)0.0372 (9)
C40.6912 (9)0.6013 (3)0.3061 (2)0.0436 (12)
H40.79560.55640.30960.052*
C50.5358 (9)0.6089 (3)0.2518 (2)0.0476 (13)
H50.53490.56900.21880.057*
C60.3791 (11)0.6756 (3)0.2457 (3)0.0564 (15)
H60.27380.68010.20860.068*
C70.3795 (12)0.7346 (3)0.2939 (3)0.0588 (15)
H70.27500.77930.28950.071*
C80.5362 (10)0.7885 (3)0.4018 (3)0.0435 (12)
C90.6946 (8)0.6604 (3)0.3564 (2)0.0337 (11)
C100.5376 (9)0.7278 (3)0.3501 (2)0.0372 (11)
O110.4054 (7)0.8506 (2)0.40120 (19)0.0653 (12)
C120.7042 (8)0.8360 (3)0.5076 (2)0.0315 (10)
C130.5181 (8)0.8382 (3)0.5557 (2)0.0354 (11)
H130.39530.79830.55630.042*
C140.5143 (9)0.8993 (3)0.6027 (2)0.0372 (11)
H140.39050.90020.63560.045*
C150.6941 (8)0.9595 (3)0.6013 (2)0.0309 (10)
C160.8821 (8)0.9566 (3)0.5533 (2)0.0344 (11)
H161.00590.99620.55280.041*
C170.8859 (8)0.8951 (3)0.5064 (2)0.0339 (11)
H171.01100.89360.47390.041*
O180.6763 (7)1.01968 (18)0.64797 (15)0.0426 (8)
H180.75831.05890.63560.064*
C190.9961 (7)0.6928 (3)0.5188 (2)0.0338 (11)
H190.96020.72300.55700.041*
C201.1845 (8)0.6398 (3)0.5204 (2)0.0341 (10)
H201.22200.61330.48040.041*
C211.3390 (9)0.6191 (3)0.5794 (2)0.0361 (11)
C221.2883 (9)0.6474 (3)0.6437 (2)0.0435 (12)
H221.15270.68160.65080.052*
C231.4371 (8)0.6252 (3)0.6973 (3)0.0498 (15)
H231.40060.64410.74020.060*
C241.6404 (9)0.5748 (3)0.6875 (3)0.0512 (14)
H241.74210.56050.72350.061*
C251.6909 (10)0.5460 (3)0.6243 (3)0.0496 (13)
H251.82650.51170.61760.060*
C261.5421 (9)0.5676 (3)0.5706 (2)0.0399 (12)
H261.57790.54750.52800.048*
U11U22U33U12U13U23
N10.0351 (19)0.030 (2)0.035 (2)0.0014 (17)−0.0054 (19)−0.0034 (17)
C20.031 (2)0.027 (2)0.037 (3)0.003 (2)−0.004 (2)−0.002 (2)
N30.041 (2)0.033 (2)0.037 (2)0.0064 (18)−0.0066 (19)−0.0067 (19)
C40.050 (3)0.038 (3)0.042 (3)0.003 (2)−0.001 (3)−0.007 (2)
C50.052 (3)0.051 (4)0.040 (3)−0.011 (3)−0.001 (3)−0.013 (3)
C60.066 (3)0.065 (4)0.038 (3)−0.002 (3)−0.017 (3)−0.007 (3)
C70.067 (3)0.059 (4)0.050 (3)0.012 (3)−0.021 (3)−0.003 (3)
C80.045 (3)0.041 (3)0.043 (3)0.004 (3)−0.012 (3)−0.001 (2)
C90.036 (2)0.034 (3)0.031 (3)−0.001 (2)−0.004 (2)−0.002 (2)
C100.044 (2)0.038 (3)0.030 (3)0.004 (2)−0.006 (2)−0.001 (2)
O110.081 (3)0.055 (3)0.060 (3)0.029 (2)−0.030 (2)−0.010 (2)
C120.031 (2)0.031 (3)0.032 (3)0.003 (2)−0.003 (2)−0.003 (2)
C130.036 (2)0.029 (3)0.041 (3)−0.009 (2)−0.001 (2)0.004 (2)
C140.039 (2)0.037 (3)0.036 (3)−0.002 (2)0.006 (2)0.003 (2)
C150.040 (2)0.027 (3)0.026 (2)−0.003 (2)−0.003 (2)0.001 (2)
C160.034 (2)0.033 (3)0.036 (3)−0.007 (2)0.001 (2)0.000 (2)
C170.032 (2)0.036 (3)0.034 (3)−0.001 (2)0.004 (2)0.001 (2)
O180.062 (2)0.0355 (19)0.0304 (17)−0.0100 (17)0.0041 (16)−0.0058 (16)
C190.038 (2)0.029 (3)0.034 (3)−0.002 (2)−0.006 (2)−0.002 (2)
C200.040 (2)0.027 (2)0.035 (3)−0.002 (2)−0.005 (2)0.000 (2)
C210.037 (2)0.030 (3)0.041 (3)−0.007 (2)−0.012 (2)0.001 (2)
C220.041 (3)0.045 (3)0.044 (3)−0.003 (2)−0.008 (2)−0.004 (3)
C230.054 (3)0.060 (4)0.036 (3)−0.010 (3)−0.009 (2)0.002 (3)
C240.047 (3)0.060 (4)0.047 (4)−0.009 (3)−0.018 (2)0.011 (3)
C250.038 (3)0.051 (3)0.059 (4)0.001 (2)−0.007 (3)0.016 (3)
C260.039 (2)0.040 (3)0.041 (3)−0.001 (2)−0.003 (2)0.003 (2)
N1—C81.385 (6)C14—H140.9300
N1—C21.404 (5)C15—O181.364 (5)
N1—C121.455 (5)C15—C161.387 (6)
C2—N31.289 (5)C16—C171.379 (6)
C2—C191.459 (6)C16—H160.9300
N3—C91.385 (5)C17—H170.9300
C4—C51.368 (7)O18—H180.8200
C4—C91.398 (6)C19—C201.335 (6)
C4—H40.9300C19—H190.9300
C5—C61.390 (7)C20—C211.475 (6)
C5—H50.9300C20—H200.9300
C6—C71.367 (7)C21—C221.389 (6)
C6—H60.9300C21—C261.390 (6)
C7—C101.406 (7)C22—C231.379 (6)
C7—H70.9300C22—H220.9300
C8—O111.241 (6)C23—C241.382 (7)
C8—C101.436 (6)C23—H230.9300
C9—C101.400 (6)C24—C251.370 (7)
C12—C171.378 (6)C24—H240.9300
C12—C131.381 (6)C25—C261.378 (7)
C13—C141.377 (6)C25—H250.9300
C13—H130.9300C26—H260.9300
C14—C151.383 (6)
C8—N1—C2121.5 (4)C15—C14—H14119.9
C8—N1—C12116.7 (4)O18—C15—C14117.4 (4)
C2—N1—C12121.8 (3)O18—C15—C16123.0 (4)
N3—C2—N1123.3 (4)C14—C15—C16119.6 (4)
N3—C2—C19119.4 (4)C17—C16—C15120.1 (4)
N1—C2—C19117.3 (4)C17—C16—H16119.9
C2—N3—C9118.6 (4)C15—C16—H16119.9
C5—C4—C9120.6 (5)C12—C17—C16120.0 (4)
C5—C4—H4119.7C12—C17—H17120.0
C9—C4—H4119.7C16—C17—H17120.0
C4—C5—C6120.6 (5)C15—O18—H18109.5
C4—C5—H5119.7C20—C19—C2121.6 (4)
C6—C5—H5119.7C20—C19—H19119.2
C7—C6—C5120.2 (5)C2—C19—H19119.2
C7—C6—H6119.9C19—C20—C21126.5 (4)
C5—C6—H6119.9C19—C20—H20116.8
C6—C7—C10120.1 (5)C21—C20—H20116.8
C6—C7—H7119.9C22—C21—C26118.3 (4)
C10—C7—H7119.9C22—C21—C20123.1 (4)
O11—C8—N1119.7 (5)C26—C21—C20118.7 (4)
O11—C8—C10124.9 (5)C23—C22—C21120.6 (5)
N1—C8—C10115.5 (4)C23—C22—H22119.7
N3—C9—C4119.4 (4)C21—C22—H22119.7
N3—C9—C10121.7 (4)C22—C23—C24120.3 (5)
C4—C9—C10118.9 (4)C22—C23—H23119.9
C9—C10—C7119.7 (4)C24—C23—H23119.9
C9—C10—C8119.5 (4)C25—C24—C23119.6 (5)
C7—C10—C8120.7 (5)C25—C24—H24120.2
C17—C12—C13120.1 (4)C23—C24—H24120.2
C17—C12—N1120.4 (4)C24—C25—C26120.4 (5)
C13—C12—N1119.3 (4)C24—C25—H25119.8
C14—C13—C12120.1 (4)C26—C25—H25119.8
C14—C13—H13120.0C25—C26—C21120.8 (5)
C12—C13—H13120.0C25—C26—H26119.6
C13—C14—C15120.1 (4)C21—C26—H26119.6
C13—C14—H14119.9
C8—N1—C2—N31.2 (7)C8—N1—C12—C17−95.4 (5)
C12—N1—C2—N3−177.5 (4)C2—N1—C12—C1783.3 (5)
C8—N1—C2—C19−176.7 (4)C8—N1—C12—C1380.1 (5)
C12—N1—C2—C194.7 (6)C2—N1—C12—C13−101.2 (5)
N1—C2—N3—C9−0.6 (6)C17—C12—C13—C14−0.3 (6)
C19—C2—N3—C9177.1 (4)N1—C12—C13—C14−175.8 (4)
C9—C4—C5—C60.2 (8)C12—C13—C14—C151.1 (7)
C4—C5—C6—C70.2 (9)C13—C14—C15—O18178.2 (4)
C5—C6—C7—C10−0.3 (9)C13—C14—C15—C16−1.8 (7)
C2—N1—C8—O11179.4 (5)O18—C15—C16—C17−178.4 (4)
C12—N1—C8—O11−1.9 (7)C14—C15—C16—C171.6 (7)
C2—N1—C8—C10−0.7 (6)C13—C12—C17—C160.1 (6)
C12—N1—C8—C10178.0 (4)N1—C12—C17—C16175.5 (4)
C2—N3—C9—C4−178.7 (4)C15—C16—C17—C12−0.7 (7)
C2—N3—C9—C10−0.3 (6)N3—C2—C19—C2017.8 (7)
C5—C4—C9—N3178.0 (4)N1—C2—C19—C20−164.3 (4)
C5—C4—C9—C10−0.5 (7)C2—C19—C20—C21−175.8 (4)
N3—C9—C10—C7−178.0 (5)C19—C20—C21—C226.9 (7)
C4—C9—C10—C70.4 (7)C19—C20—C21—C26−174.5 (4)
N3—C9—C10—C80.7 (7)C26—C21—C22—C230.4 (7)
C4—C9—C10—C8179.1 (4)C20—C21—C22—C23179.0 (4)
C6—C7—C10—C90.0 (8)C21—C22—C23—C240.5 (7)
C6—C7—C10—C8−178.7 (5)C22—C23—C24—C25−1.0 (7)
O11—C8—C10—C9179.8 (5)C23—C24—C25—C260.6 (8)
N1—C8—C10—C9−0.2 (6)C24—C25—C26—C210.3 (7)
O11—C8—C10—C7−1.6 (8)C22—C21—C26—C25−0.8 (7)
N1—C8—C10—C7178.5 (5)C20—C21—C26—C25−179.5 (4)
D—H···AD—HH···AD···AD—H···A
O18—H18···O11i0.821.842.654 (5)172
C4—H4···Cg4ii0.942.963.829 (5)157
C16—H16···Cg3i0.942.953.646 (5)133
  9 in total

1.  Quinazolin-4-one alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists: structure-activity relationship of the C-2 side chain tether.

Authors:  B L Chenard; W M Welch; J F Blake; T W Butler; A Reinhold; F E Ewing; F S Menniti; M J Pagnozzi
Journal:  J Med Chem       Date:  2001-05-24       Impact factor: 7.446

2.  The Cambridge Structural Database in retrospect and prospect.

Authors:  Colin R Groom; Frank H Allen
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-02       Impact factor: 15.336

3.  A novel class of Hsp90 inhibitors isolated by structure-based virtual screening.

Authors:  Hwangseo Park; Yun-Jung Kim; Ji-Sook Hahn
Journal:  Bioorg Med Chem Lett       Date:  2007-09-01       Impact factor: 2.823

4.  Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one.

Authors:  Renee Bouley; Malika Kumarasiri; Zhihong Peng; Lisandro H Otero; Wei Song; Mark A Suckow; Valerie A Schroeder; William R Wolter; Elena Lastochkin; Nuno T Antunes; Hualiang Pi; Sergei Vakulenko; Juan A Hermoso; Mayland Chang; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2015-02-02       Impact factor: 15.419

5.  Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors.

Authors:  Kasper B Hansen; Stephen F Traynelis
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

6.  Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents.

Authors:  Ahmed Kamal; E Vijaya Bharathi; M Janaki Ramaiah; D Dastagiri; J Surendranadha Reddy; A Viswanath; Farheen Sultana; S N C V L Pushpavalli; Manika Pal-Bhadra; Hemant Kumar Srivastava; G Narahari Sastry; Aarti Juvekar; Subrata Sen; Surekha Zingde
Journal:  Bioorg Med Chem       Date:  2009-12-11       Impact factor: 3.641

7.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

8.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20

9.  Synthesis and antileishmanial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives.

Authors:  Yihenew Simegniew Birhan; Adnan Ahmed Bekhit; Ariaya Hymete
Journal:  Org Med Chem Lett       Date:  2014-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.